Consider a clinical trial for people with communication challenges due to autism spectrum disorder (ASD).
See if you or your loved one may qualify.
The IRIS clinical trial is evaluating an oral investigational medication, ML-004, to see if it may help alleviate some of the symptoms that interfere with communication in those with autism spectrum disorder (ASD).
Participants may be able to take part in the clinical trial if they:
*The clinical trial/care partner is someone who lives with or has frequent contact with the clinical trial participant (parent, spouse, friend, etc.) and is willing and able to provide information about the participant and attend some trial visits.
The clinical trial team will discuss additional eligibility criteria with you.
© MapLight | Privacy | Expanded Access Policy
